Has Harry Anastos, MD received payments from drug or device companies?

Yes. Drug and device makers reported $28,883 in general payments to Harry Anastos, MD across 54 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Harry Anastos, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Harry Anastos, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Harry Anastos, MD

Urology · New York, NYNPI 1851895353

Payments from drug & device makers

$28,883in general payments, 2019–2025

Across 54 payments — averaging $534.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$27K
Urogen Pharma, Inc.$504
Coloplast$340
Procept Biorobotics Corporation$333
Sumitomo Pharma America, Inc.$206
Ferring Pharmaceuticals Inc.$168
plus $566 from 7 others

What the payments were for

Grants$25,00087%
Food & beverage$3,72513%
Education$1581%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	17	$26,766
Urogen Pharma, Inc.	10	$504
Coloplast	6	$340
Procept Biorobotics Corporation	2	$333
Sumitomo Pharma America, Inc.	9	$206
Ferring Pharmaceuticals Inc.	2	$168
Calyxo, Inc.	2	$158
Olympus America Inc.	1	$150
Laborie Medical Technologies Corp.	1	$100
Johnson & Johnson	1	$89
Immunitybio, Inc.	1	$27
Intuitive Surgical	1	$24
Progenics Pharmaceuticals, Inc.	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$28,883 in reported general payments places this provider in the 85th percentile of 952 urology providers in New York.

See all urology providers in New York →

Medicare billing

Part B allowed, 2024

$100,009

Medicare patients

329

Services billed

2,188

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Tamsulosin Hcl	40	$545

Paid to pharmacies, not to this prescriber.

Other urology in New York

Guarionex DecastroNew York$5.7M
James McKiernanNew York$4.1M
William HuangNew York$3.9M
Ashutosh TewariNew York$2.5M
Bilal ChughtaiNew York$1.5M
Nils Peter WiklundNew York$1M
Herbert LeporNew York$823K
Christopher AndersonNew York$785K
Katie MurrayNew York$776K
John SfakianosNew York$726K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →